Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iCura Diagnostics is a leading CRO and diagnostics laboratory specializing in advanced histology/pathology services—including multiplex IHC/mIF—and comprehensive genomics solutions. The company is CLIA/CAP certified and serves pharmaceutical companies and academic centers with validated platforms supporting precision medicine initiatives in oncology and other disease areas. It is recognized as the first fully qualified multiplex IHC/IF service partner of Akoya Biosciences. No direct therapeutic programs or clinical trial results as it is a service provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iCura Diagnostics.